Nightingale, Paul and Martin, Paul (2004) The myth of the biotech revolution. Trends in Biotechnology, 22 (11). pp. 564-569. ISSN 0167-7799

Full text not available from this repository.

Abstract

The existence of a medicinal biotech revolution has been widely accepted and promoted by academics, consultants, industry and government. This has generated expectations about significant improvements in the drug discovery process, healthcare and economic development that influence a considerable amount of previous termpolicynext term-making. Here we present empirical evidence, from a variety of indicators, that shows that a range of outputs have failed to keep pace with increased previous termresearchnext term and development spending. Rather than producing revolutionary changes, medicinal biotechnology is following a well-established pattern of slow and incremental technology diffusion. Consequently, many expectations are wildly optimistic and over-estimate the speed and extent of the impact of biotechnology, suggesting that the assumptions underpinning much contemporary policymaking need to be rethought.

Item Type:	Article
Schools and Departments:	University of Sussex Business School > SPRU - Science Policy Research Unit
Depositing User:	Paul Nightingale
Date Deposited:	06 Feb 2012 19:53
Last Modified:	03 Apr 2012 09:39
URI:	http://sro.sussex.ac.uk/id/eprint/22826

📧 Request an update